Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in hypertension management: update 1998.

A Cases1

  • 1Department of Nephrology, Hospital Clinic, Barcelona, Spain.

Drugs of Today (Barcelona, Spain : 1998)
|January 27, 2004
PubMed
Summary

This review summarizes recent hypertension management findings, including major clinical trial outcomes and cancer risks with antihypertensive drugs. It also discusses ACE inhibitors

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study.

The journal of headache and pain·2025
Same author

Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.

Drugs of today (Barcelona, Spain : 1998)·2018
Same author

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Journal of thrombosis and haemostasis : JTH·2018
Same author

[Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].

Semergen·2017
Same author

Efficacy of a simple dosage scheme to convert from shorter-acting erythropoiesis-stimulating agent to continuous erythropoietin receptor activator in kidney transplantation patients.

Transplantation proceedings·2015
Same author

[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010

Area of Science:

  • Cardiology
  • Nephrology
  • Oncology

Background:

  • Recent advancements in hypertension management require updated clinical guidance.
  • Large-scale clinical trials and retrospective studies offer new insights into treatment efficacy and safety.

Purpose of the Study:

  • To review key recent findings in hypertension management.
  • To summarize results from major clinical trials like Syst-Eur, HOT, and CAPPP.
  • To discuss cancer risks, nephroprotective effects of ACE inhibitors, and cardiovascular risks of dihydropyridine calcium antagonists.

Main Methods:

  • Review of published literature and medical congress presentations.
  • Summarization of results from large outcome clinical trials.
  • Analysis of retrospective studies on antihypertensive treatments and cancer risk.

Main Results:

  • Key findings from Syst-Eur, HOT, and CAPPP trials are presented.
  • Retrospective studies on cancer risk associated with antihypertensive treatments are discussed.
  • Nephroprotective effects of ACE inhibitors and cardiovascular risks of dihydropyridine calcium antagonists are evaluated.

Conclusions:

  • Recent trials provide crucial data for optimizing hypertension management.
  • Understanding treatment-specific risks, such as cancer and cardiovascular events, is essential.
  • Angiotensin-converting enzyme inhibitors show promise in protecting kidneys, while dihydropyridine calcium antagonists warrant careful consideration regarding cardiovascular risk.

Related Experiment Videos